Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: More of a thought that should be discussed with a lawyer I suppose

In the back of my mind, there remains the hope that this plays out well for long time ptsc shareholders. We found that because of Leckrone's past lowball settlements, PTSC was not going to get huge judgements from a jury. However, because of the past year of proving Leckrone was a lying slimeball who used MMP to entice companies to purchase his other patent licenses, we may invalidate the past settlements and do not reflect the true value of MMP. If that was true, even this late in the patent life, it seems (when I wear these rose colored glasses) that a few settlements would and could proved over $1/share to shareholders. I have read of huge settlements being awarded. I realize this is perhaps overly optomistic but with so many reviews and challenges, it seems infringers were worried for a reason. They could not invalidate the patent so they basically bought off Leckrone. At least that's how I see it. I would like to hear our BoD' s plan for getting this huge payday (not their monthly huge payday that they take individually).

6
Apr 26, 2015 05:25AM
Share
New Message
Please login to post a reply